User talk:Angelovasta

Hello Angelovasta. The nature of your edits gives the impression you have an undisclosed financial stake in promoting a topic, and that you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially egregious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to Black hat SEO.

Paid advocates are very strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists, and if it does not, from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are  required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:Angelovasta. The template Paid can be used for this purpose – e.g. in the form:. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, please do not edit further until you answer this message. -- Ed (Edgar181) 15:27, 16 May 2018 (UTC)

--Angelovasta (talk) 14:27, 17 May 2018 (UTC) -- Ed, thank you for your reply and for taking the time to explain what was apparently wrong with the post. We were not aware about the Paid contribution guidelines and we believe that the verbage was similar to this one describing and referencing Solesta.

I am an employee of MPP Group LLC and I am paid as an employee. I was not paid extra for this post. The idea behind it was to inform the readers about Dextranomer powder being reintroduced to the market by MPP.

As you may know, Debrisan is only sold in Mexico, albeit it was also sold in the US in the seventies.

We are very excited about Dextranomer and its unique wound healing properties. e.g., exudate removal and debridement. We also have formulated two other advanced wound care products based on pure Dextranomer powder in which its wound healing activities were additionally reinforced by addition of Chitosan, which is a known bacteriostatic agent. These products have received a great acceptance by wound care professionals throughout the US.

Kindly please let me know if this response suffices (and if so, please repost my last edits), or what modifications you would like us to introduce to make this post publishable.

Sincerely,


 * Thanks for letting me know your situation. The edits I removed were promotional in nature (highlighting brand names, adding trademark symbols, adding repeated links to your website, etc.)  In addition, medical content should be sourced to reliable independent secondary sources (see WP:MEDRS)  However, regardless of the content of your edits, Wikipedia's conflict of interest guidelines recommend that you do not edit the article at all under these circumstances.  Here is a page that you might find helpful:  Plain and simple conflict of interest guide.   Regards,  -- Ed (Edgar181) 20:42, 17 May 2018 (UTC)